Effects of Core Stabilization and Inspiratory Muscle Training in Patients With COPD
Launched by MUSTAFA ERTUĞRUL YAŞA · Jul 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different types of training—one for the muscles we use to breathe (inspiratory muscle training) and another for stabilizing our core (core stabilization training)—can help people with Chronic Obstructive Pulmonary Disease (COPD). The goal is to see which training method better improves breathing strength, physical activity, and overall quality of life for individuals with COPD. This is important because strong respiratory muscles can make it easier to breathe and be active, which can positively affect health and well-being.
To participate in this study, individuals need to be over 18 years old and have a diagnosed stage 3 or lower COPD. They should not be experiencing any recent flare-ups of their condition, and they must be able to walk independently and understand the study tasks. Participants will undergo training sessions and will be monitored for improvements in their breathing and physical abilities. It's a great opportunity for those looking to enhance their lung function and everyday life with COPD!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being over 18 years old
- • Having a diagnosis of COPD according to the GOLD criteria and being at stage 3 or lower
- • Not being in an acute exacerbation period and having at least one month since the last exacerbation
- • Being able to walk independently
- • Having sufficient mental capacity to understand the tasks in the study (Mini-Mental Test \>24)
- • Being willing to participate in the study
- Exclusion Criteria:
- • Being a stage 4 COPD patient according to the GOLD criteria
- • Having a diagnosis of lung cancer, pulmonary hypertension, and heart failure
- • Being in a COPD exacerbation period
- • Scoring below 24 on the Mini-Mental Test
- • Having any other disease that affects respiratory functions
- • Having undergone pulmonary surgery
About Mustafa Ertuğrul Yaşa
Mustafa Ertuğrul Yaşa is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, the organization collaborates with leading healthcare professionals and institutions to design and execute rigorous clinical trials. Mustafa Ertuğrul Yaşa emphasizes ethical standards, scientific integrity, and patient safety, ensuring that each study is conducted with the utmost care and precision. By fostering a culture of collaboration and excellence, the organization aims to contribute significantly to the development of effective treatments across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported